CVS Health (CVS) named Ed DeVaney president of the company’s CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report to Prem Shah ...

Today, CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report ...

In a report released on February 14, Steven Silver from Argus Research maintained a Buy rating on CVS Health (CVS – Research Report). The company’s shares closed last Friday at $65.83.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CVS Health recently acquired home healthcare agency, Signify Health, for a whopping $8 billion. With the biggest players across the healthcare industry interested in making an offer, I only expect ...

Microsoft and CVS Health have announced a new strategic alliance focusing on personalised care and accelerating digital transformation for the benefit of CVS customers and its employees.

Following a disappointing 2024, shares of CVS Health are way up in 2025. Despite rising sharply, CVS Health stock offers a high dividend yield. The company's dividend has risen by 90% over the ...

In this article, we are going to take a look at where CVS Health Corporation (NYSE ... Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has ...